J. Nick Riehle - 08 Sep 2025 Form 4 Insider Report for ADAPTIN BIO, INC.

Reporting relationship
Director
Issuer ticker
APTN on OTC
Reported as of
08 Sep 2025
Net transaction value
$0
Source evidence Original filing metadata and source links for verification. 4 source fields
SEC form
4
Accepted by SEC
10 Sep 2025, 17:00:41 UTC
Prior SEC filing
18 Feb 2025
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ S. Halle Vakani, Attorney-in-Fact

Key filing fact

J. Nick Riehle filed Form 4 for ADAPTIN BIO, INC. on 10 Sep 2025.

Key facts

  • This page summarizes J. Nick Riehle's Form 4 filing for ADAPTIN BIO, INC..
  • 1 reported transaction and 1 derivative row are listed below.
  • Accepted by SEC: 10 Sep 2025, 17:00.

Change

  • Previous filing in this sequence was filed on 18 Feb 2025.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001316746 Primary reporting owner

Riehle J Nick

Relationship
Director
Address
3540 TORINGDON WAY, SUITE 200, #250, CHARLOTTE
Signature
/s/ S. Halle Vakani, Attorney-in-Fact
Signature date
10 Sep 2025

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

No ticker transaction Derivative

Stock Option (right to buy)

Award

Transaction value
$0
Shares
+109,847
Change %
Price
$0.000000
Shares after
109,847
Date
08 Sep 2025
Ownership
Direct
Underlying class
Common Stock
Underlying amount
109,847
Exercise price
$4.40
Footnotes
F1
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

The stock option vests in equal monthly installments on the last day of each calendar month over 48 months beginning on September 8, 2025.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .